Latest filingSep 01, 2026Most recent Form 4
AURA
Aura Biosciences, Inc.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$05 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period10transactions
- A · Grants / awards · dominant10 · 100%
Activity by reported role
A joint filing can contribute to multiple roles14transactions
- CMO · dominant2 · 14%
- COO2 · 14%
- CPO2 · 14%
- CR2 · 14%
- PAO2 · 14%
- QO2 · 14%
- SVP2 · 14%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (5)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeAbu-Absi SusanCommon Stock · Direct
134,513Sep 01, 2026
Abu-Absi SusanStock Option (Right to Buy) · Direct
265,487Sep 01, 2026
Elazzouzi AmyStock Option (Right to Buy) · Direct
46,460Sep 01, 2026
Elazzouzi AmyCommon Stock · Direct
143,600Sep 01, 2026
Hopkins Janet JillCommon Stock · Direct
380,190Sep 01, 2026
Hopkins Janet JillStock Option (Right to Buy) · Direct
116,150Sep 01, 2026
Kratz EricaStock Option (Right to Buy) · Direct
199,115Sep 01, 2026
Kratz EricaCommon Stock · Direct
100,885Sep 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
AURA transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
No transactions match your filtersOnce the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range. | ||||||||||
Aura Biosciences, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Aura Biosciences, Inc.?
Person Julie, Kratz Erica, Hopkins Janet Jill, Elazzouzi Amy, Abu-Absi Susan.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.